𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Remicade® Does Not Abolish the Need for Surgery in Fistulizing Crohn’s Disease

✍ Scribed by LisaS. Poritz; WilliamA. Rowe; WalterA. Koltun


Publisher
Springer
Year
2002
Tongue
English
Weight
382 KB
Volume
45
Category
Article
ISSN
0012-3706

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Cytokine network in rectal mucosa in per
✍ Cesare Ruffolo; Marco Scarpa; Diego Faggian; Anna Pozza; Filippo Navaglia; Renat 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Background: Nowadays anti-TNF-␣ antibodies are used for the treatment of perianal Crohn's disease (CD). Nevertheless, this treatment is effective in only a part of these patients and recent studies suggested a role for other cytokines in chronic bowel inflammation. The aim of this study was to asses

Small bowel resection rates in Crohn's d
✍ Mark Lazarev; Thomas Ullman; Wolfgang H. Schraut; Kevin E. Kip; Melissa Saul; Mi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 1 views

Background: Our primary aim was to determine if the rate of small bowel resection (SBR) has declined over time among Crohn's disease (CD) patients seen at a single academic institution. A secondary aim was to establish whether the indication for surgery has changed. ## Methods: Patients with a pr

Seroreactivity to microbial components i
✍ Maria Papp; Istvan Altorjay; Gary L. Norman; Zakera Shums; Karoly Palatka; Zsuzs 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 2 views

Background: Antibodies directed against Saccharomyces cerevisiae (ASCA), perinuclear components of neutrophils (pANCA), and porin protein C of Escherichia coli (anti-OmpC) are reported to be associated with disease phenotype and may be of diagnostic importance in inflammatory bowel disease (IBD). Si